Numerous publications have underlined the link between complement C5a and the clinical course of COVID-19. We previously reported that levels of C5a remain high in the group of severely ill patients u
Development of vaccines to preserve and improve human and animal health require effective protective antigens, delivery platforms and adjuvants. The immunostimulant adjuvant based on heat-inactivated